In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
During the COVID-19 pandemic he was part of the “public face” for media and community groups, conducting over 100 interviews, seminars and media conferences, including with the Prime Minister and Health Minister.
He became synonymous with, and the public face of, the Therapeutic Goods Administration, leaving behind an extraordinary record of public service.
During this time it was his reassurances that left Australians confident in the approval and regulation of medicines, vaccines and treatments.
“Professor Skerritt has had many achievements over the course of his career including Implementing the Medicines and Medical Devices Review, digital transformation, the regulation of medicinal cannabis, the rapid registration of COVID vaccines and treatments and playing a leading role in international harmonisation of regulation.”, said The Hon Mark Butler MP, Minister for Health and Aged Care in a press release issued in February the same year.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
About ARCS and its transformation in 2023
ARCS Australia is the association for people working on the development of therapeutics. The ARCS conference brings over 1500 people across the sector, in Australia, with international speakers coming this year. The conference runs over 3 days with 7 concurrent streams that cover all the areas that are involved in the development of therapeutics, including clinical research, regulatory affairs and pharmacovigilance.
The focus for ARCS at this year’s conference has been building competency frameworks in the areas that members work. As a significant step, ARCS is transforming into a professional body that both recognises and develops people into specific competencies that are required for the roles that those people are undertaking.
Dr Shanny Dyer states, “One of the key goals that ARCS is undertaking over this strategic period is to implement the professionalisation of our sector. Whilst we’ve been very clearly developing products that have safety, quality and efficacy, we now need to work on the quality of our staff, their ability to develop products and have a safe pair of hands and to work efficiently as well.”
-
Detection and prevention of Alzheimer’s Disease and Related Dementias
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
-
Psychiatrists to discuss connectedness at RANZCP 2023 Congress
Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.
-
Australasian College of Paramedicine makes case for multi-disciplinary care
Despite being seen primarily as emergency responders, paramedics have long been providing care in the primary care space. As such, their increased involvement in primary and urgent care is a natural progression that can lead to improved health outcomes for communities. Urgent care clinics, which treat non-life-threatening injuries and illnesses, have been a recent introduction. However, when these clinics were initially proposed, paramedics were left out of the opportunity, despite being experts in urgent, acute, unplanned, and unscheduled care. They work in these types of situations every day in the ambulance service and should be utilised in these clinics to improve patient outcomes. Working as part of multidisciplinary teams with doctors and nurses can further enhance the outcomes for local communities.
